Literature DB >> 11423595

Quadruple therapy for symptomatic spontaneous duodenal ulcer disease.

M C Bateson1.   

Abstract

AIM: To investigate Helicobacter pylori eradication in duodenal ulcer patients with a new regimen, lansoprazole 30 mg daily for one or four weeks plus twice daily tetracycline 500 mg, clarithromycin 250 mg, and metronidazole 400 mg.
BACKGROUND: Spontaneous duodenal ulcer is regularly associated with H pylori, and permanent cure follows eradication of this bacterium. Numerous treatments have been proposed and none is ideal, possibly because of primary or acquired antibiotic resistance. Quadruple regimens with proton pump inhibitor therapy and three antibiotics offer promise as the most effective therapy.
METHODS: From November 1995 all patients with spontaneous duodenal ulcer were offered quadruple therapy. A month after completion a carbon 14 urea breath test (UBT) was performed. Sensitivity of H pylori to the antibiotics used was tested in 1992-3, 1996, and 1999.
RESULTS: A total of 331 patients were treated; 313 attended for a UBT, of which 299 were negative (95.5%). Of those patients who had an endoscopy with positive urease test immediately before treatment, 95/101 (94.0%) on lansoprazole for one week and 116/121 (95.8%) on lansoprazole for four weeks had a negative UBT. H pylori antibiotic sensitivity did not change.
CONCLUSION: This regimen produced some of the best results yet seen and may be generally recommended as first line therapy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11423595      PMCID: PMC1760969          DOI: 10.1136/pmj.77.909.447

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  23 in total

Review 1.  Regular review: treatment of Helicobacter pylori infection.

Authors:  W A de Boer; G N Tytgat
Journal:  BMJ       Date:  2000-01-01

2.  Explanations for high rates of eradication with triple therapy using metronidazole in patients harboring metronidazole-resistant Helicobacter pylori strains.

Authors:  A A van Zwet; J C Thijs; B de Graaf
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

3.  Omeprazole provides quicker symptom relief and duodenal ulcer healing than ranitidine.

Authors:  R J McFarland; M C Bateson; J R Green; D P O'Donoghue; M W Dronfield; P W Keeling; G J Burke; R J Dickinson; D R Shreeve; E M Peers
Journal:  Gastroenterology       Date:  1990-02       Impact factor: 22.682

Review 4.  A systematic review of Helicobacter pylori eradication therapy--the impact of antimicrobial resistance on eradication rates.

Authors:  M H Houben; D van de Beek; E F Hensen; A J de Craen; E A Rauws; G N Tytgat
Journal:  Aliment Pharmacol Ther       Date:  1999-08       Impact factor: 8.171

5.  Comparison of three methods for the determination of the sensitivity of Helicobacter pylori to metronidazole.

Authors:  A M Hirschl; M M Hirschl; M L Rotter
Journal:  J Antimicrob Chemother       Date:  1993-07       Impact factor: 5.790

6.  Eradication of Helicobacter pylori and prevention of recurrence of duodenal ulcer: a randomized, double-blind, multi-centre trial of omeprazole with or without clarithromycin.

Authors:  R P Logan; K D Bardhan; L R Celestin; A Theodossi; K R Palmer; P I Reed; J H Baron; J J Misiewicz
Journal:  Aliment Pharmacol Ther       Date:  1995-08       Impact factor: 8.171

7.  Randomised controlled trial of short term treatment to eradicate Helicobacter pylori in patients with duodenal ulcer.

Authors:  S W Hosking; T K Ling; M Y Yung; A Cheng; S C Chung; J W Leung; A K Li
Journal:  BMJ       Date:  1992-08-29

8.  Experience with 'triple' anti-Helicobacter pylori eradication therapy: side effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resistance.

Authors:  G D Bell; K Powell; S M Burridge; A Pallecaros; P H Jones; P W Gant; G Harrison; J E Trowell
Journal:  Aliment Pharmacol Ther       Date:  1992-08       Impact factor: 8.171

9.  The E test for antimicrobial susceptibility testing of Helicobacter pylori.

Authors:  G Cederbrant; G Kahlmeter; A Ljungh
Journal:  J Antimicrob Chemother       Date:  1993-01       Impact factor: 5.790

10.  Omeprazole enhances efficacy of triple therapy in eradicating Helicobacter pylori.

Authors:  T J Borody; P Andrews; G Fracchia; S Brandl; N P Shortis; H Bae
Journal:  Gut       Date:  1995-10       Impact factor: 23.059

View more
  2 in total

1.  Treatment of Helicobacter pylori in surgical practice: a randomised trial of triple versus quadruple therapy in a rural district general hospital.

Authors:  Siok-Siong Ching; Sivakumaran Sabanathan; Lloyd-R Jenkinson
Journal:  World J Gastroenterol       Date:  2008-06-28       Impact factor: 5.742

Review 2.  Non-invasive diagnostic tests for Helicobacter pylori infection.

Authors:  Lawrence Mj Best; Yemisi Takwoingi; Sulman Siddique; Abiram Selladurai; Akash Gandhi; Benjamin Low; Mohammad Yaghoobi; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2018-03-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.